[1]Alam M, Kashyap T, Pramanik KK, et al.The elevated activation of NFκB and AP-1 is correlated with differential regulation of Bcl-2 and associated with oral squamous cell carcinoma progression and resistance[J].Clin Oral Investig, 2017, :-[2]刘盼, 多力昆·吾甫尔.鳞状细胞癌抗原在口腔鳞癌诊治中的应用[J].现代口腔医学杂志, 2017, 31(1):49-52[3]Routray S, Sunkavali A, Bari KA.Carcinoma-associated fibroblasts, its implication in head and neck squamous cell carcinoma: a mini review[J].Oral Dis, 2014, 20(3):246-253[4]Augsten M.Cancer-associated fibroblasts as another polarized cell type of the tumor microenvironment[J].Front Oncol, 2014, 4:62-[5]Takahashi H, Sakakura K, Kawabata-Iwakawa R, et al.Immunosuppressive activity of cancer-associated fibroblasts in head and neck squamous cell carcinoma[J].Cancer Immunol Immunother, 2015, 64(11):1407-1417[6]Gurtner GC, Werner S, Barrandon Y, et al.Wound repair and regeneration[J].Nature, 2008, 453(7193):314-321[7]Bai YP, Shang K, Chen H, et al.FGF-1/-3/FGFR4 signaling in cancer-associated fibroblasts promotes tumor progression in colon cancer through Erk and MMP-7[J].Cancer Sci, 2015, 106(10):1278-1287[8]Song T, Dou C, Jia Y, et al.TIMP-1 activated carcinoma-associated fibroblasts inhibit tumor apoptosis by activating SDF1/CXCR4 signaling in hepatocellular carcinoma[J].Oncotarget, 2015, 6(14):12061-12079[9]Santi A, Caselli A, Ranaldi F, et al.Cancer associated fibroblasts transfer lipids and proteins to cancer cells through cargo vesicles supporting tumor growth[J].Biochim Biophys Acta, 2015, 1853(12):3211-3223[10]Takahashi H, Sakakura K, Kawabata-Iwakawa R, et al.Immunosuppressive activity of cancer-associated fibroblasts in head and neck squamous cell carcinoma[J].Cancer Immunol Immunother, 2015, 64(11):1407-1417[11]Virchow RLK.Die Cellularpathologie: in ihrer Begründung auf physiologische und pathologische Gewebelehre[M]. Berlin:Verlag von August Hirschwald, No. 68, 1871.[12]Darby IA, Laverdet B, Bonté F, et al.Fibroblasts and myofibroblasts in wound healing[J].Clin Cosmet Investig Dermatol, 2014, 7:301-311[13]?hlund D, Elyada E, Tuveson D.Fibroblast heterogeneity in the cancer wound[J].J Exp Med, 2014, 211(8):1503-1523[14]Ishii G, Ochiai A, Neri S.Phenotypic and functional heterogeneity of cancer-associated fibroblast within the tumor microenvironment[J].Adv Drug Deliv Rev, 2016, 99(Pt B):186-196[15]Guido C, Whitaker-Menezes D, Capparelli C, et al.Metabolic reprogramming of cancer-associated fibroblasts by TGF-β drives tumor growth: connecting TGF-β signaling with "Warburg-like" cancer metabolism and L-lactate production[J].Cell Cycle, 2012, 11(16):3019-3035[16]Simpkins SA, Hanby AM, Holliday DL, et al.Clinical and functional significance of loss of caveolin-1 in breast cancer-associated fibroblasts[J].J Pathol, 2012, 227(4):490-498[17]Goetz JG, Minguet S, Navarro-Lérida I, et al.Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis[J].Cell, 2011, 146(1):148-163[18]LeBleu VS, Taduri G, O'Connell J, et al.Origin and function of myofibroblasts in kidney fibrosis[J].Nat Med, 2013, 19(8):1047-1053[19]Quante M, Tu SP, Tomita H, et al.Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth[J].Cancer Cell, 2011, 19(2):257-272[20]Orimo A, Gupta PB, Sgroi DC, et al.Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion[J].Cell, 2005, 121(3):335-348[21]Kalluri R.The biology and function of fibroblasts in cancer[J].Nat Rev Cancer, 2016, 16(9):582-598 |